CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat β-Thalassemia
New England Journal of Medicine · 02.04.2026 · 394 (13) · 1292-1301
DOI: 10.1056/nejmoa2501277 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift New England Journal of Medicine, erschienen am 02.04.2026. Verfasst von Haydar Frangoul und 14 weiteren Autor:innen. Beteiligte Einrichtung: Sarah Cannon Research Institute, Nashville. Hauptthemen laut MEDLINE: beta-Thalassemia, CRISPR-Cas Systems, Fetal Hemoglobin, gamma-Globins. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 26 Literaturangaben. Gefördert von: Editas Medicine, Inc..
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Sarah Cannon Research Institute, Nashville.
- TriStar Centennial Children's Hospital, Nashville.
- Department of Pediatric Hematology, Oncology, and Blood and Marrow Transplantation, Cleveland Clinic, Cleveland.
- School of Medicine, University of California, San Francisco, San Francisco.
- Benioff Children's Hospital, Oakland, CA.
- Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis.
ORCID-Profile: Haydar Frangoul, Rabi Hanna, Mark C Walters, Alexis Thompson
Förderung
- Editas Medicine, Inc.
Zitieren
APA
Frangoul, H., Hanna, R., Walters, M. C., Kao, R. L., Carroll, C., McManus, M., Chang, K. H., Jaskolka, M. C., Kim, K., Yu, Q., Badamosi, N., Mei, B., Afonja, O., Thompson, A., & EdiThal Investigators (2026). CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat β-Thalassemia. New England Journal of Medicine, 394(13), 1292-1301. https://doi.org/10.1056/nejmoa2501277
Vancouver
Frangoul H, Hanna R, Walters MC, Kao RL, Carroll C, McManus M, et al. CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat β-Thalassemia. New England Journal of Medicine. 2026;394(13):1292-1301. doi:10.1056/nejmoa2501277
BibTeX
@article{Frangoul2026,
author = {Frangoul, Haydar and Hanna, Rabi and Walters, Mark C and Kao, Roy L and Carroll, Clinton and McManus, Meghann and Chang, Kai-Hsin and Jaskolka, Michael C and Kim, Keunpyo and Yu, Qifeng and Badamosi, Nnenna and Mei, Baisong and Afonja, Olubunmi and Thompson, Alexis and EdiThal Investigators, EdiThal Investigators},
title = {CRISPR-Cas12a Gene Editing of HBG1 and HBG2 Promoters to Treat β-Thalassemia},
journal = {New England Journal of Medicine},
year = {2026},
volume = {394},
number = {13},
pages = {1292--1301},
doi = {10.1056/nejmoa2501277}
}
EUVIMED